UCLA shortstop Roch Cholowsky, the No. 1 pick by the Chicago White Sox in the 2026 MLB Draft, has signed a record-setting deal for largest bonus in MLB Draft history. Cholowsky agreed to a $10.35 ...

The World Trade Center hasn’t seen so much positive news since before 9/11. Ground was broken last week for the new Amex headquarters at Two World Trade Center, which will complete the site’s quartet ...

Boston University will pay the city of Boston $104 million in cash and other benefits over the next five years as part of a payment in lieu of taxes—or PILOT—agreement, The Boston Globe reported. It’s ...

Seven consumers have filed a proposed class action lawsuit against Costco, alleging the company sold Orgain Organic Protein Powder without disclosing the presence of lead, cadmium, and arsenic, ...

The Dark Energy Camera reveals the stunning Corona Australis Molecular Cloud, featuring nebulae, dust lanes, and young stars. Stranded Red Arrows forced to pull out of UK airshows Attempted murder ...

The most notable name among NFL insiders is remaining at ESPN. Adam Schefter and the "Worldwide Leader" have agreed to a multi-year extension, ESPN announced Monday, July 13. Front Office Sports first ...

SPRING HILL, Fla. (WFLA) — An arrest was made following an investigation into a series of incidents and the discovery of a suspicious package in the driveway of a Hernando County residence. On July 6, ...

"Hearst Magazines and AOL may earn commission or revenue on some items through these links." It’s no secret that the pixie haircut has suddenly come back into fashion—in part because it is inherently ...

Prysmian SpA signed a deal worth as much €5.5 billion ($6.3 billion) to supply Koch Inc.’s Molex with optical cables for its data centers, tapping into the artificial-intelligence build-out. The ...

Alibaba's U.S.-listed shares rose in premarket trading on Wednesday after news that its Qwen AI model would be integrated into Apple services in China. "Qwen will be integrated into Apple Intelligence ...

A U.S.-based rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-known medicine and set its sights on a $50 million fundraise. Ashlins ...